Zia Shariat-Madar

Summary

Affiliation: University of Mississippi
Country: USA

Publications

  1. ncbi request reprint Influence of a novel inhibitor (UM8190) of prolylcarboxypeptidase (PRCP) on appetite and thrombosis
    F M Rabey
    School of Pharmacy, Department of Pharmacology, University of Mississippi, University, MS 38677 1848, USA
    Curr Med Chem 19:4194-206. 2012
  2. doi request reprint Prolylcarboxypeptidase: a cardioprotective enzyme
    J Mallela
    The School of Pharmacy, Department of Pharmacology, University of Mississippi, University, MS 38677 1848, USA
    Int J Biochem Cell Biol 41:477-81. 2009
  3. ncbi request reprint PF-04886847 (an inhibitor of plasma kallikrein) attenuates inflammatory mediators and activation of blood coagulation in rat model of lipopolysaccharide (LPS)-induced sepsis
    D Kolte
    School of Pharmacy, Department of Pharmacology, University of Mississippi, University, MS 38677 1848, USA
    Cardiovasc Hematol Agents Med Chem 10:154-66. 2012
  4. pmc Upregulation of prolylcarboxypeptidase (PRCP) in lipopolysaccharide (LPS) treated endothelium promotes inflammation
    My Linh Ngo
    School of Pharmacy, Department of Pharmacology, University of Mississippi, Oxford, MS, USA
    J Inflamm (Lond) 6:3. 2009

Collaborators

  • S Diano
  • F M Rabey
  • D Kolte
  • J Mallela
  • My Linh Ngo
  • T Tabrizian
  • Q Cheng
  • J Wang
  • R S V S Gadepalli
  • J M Rimoldi
  • J W Bryant
  • G W Gibson
  • D Gailani
  • J Yang
  • Dhaval Kolte
  • Fakhri Mahdi

Detail Information

Publications4

  1. ncbi request reprint Influence of a novel inhibitor (UM8190) of prolylcarboxypeptidase (PRCP) on appetite and thrombosis
    F M Rabey
    School of Pharmacy, Department of Pharmacology, University of Mississippi, University, MS 38677 1848, USA
    Curr Med Chem 19:4194-206. 2012
    ..UM8190 is a selective PRCP inhibitor and it may represent a new anorexigenic, and antithrombotic drug, that works by inhibiting PRCP-mediated mechanisms...
  2. doi request reprint Prolylcarboxypeptidase: a cardioprotective enzyme
    J Mallela
    The School of Pharmacy, Department of Pharmacology, University of Mississippi, University, MS 38677 1848, USA
    Int J Biochem Cell Biol 41:477-81. 2009
    ..The anti-hypertensive and proinflammatory properties of PRCP implicate that this enzyme may well be an accessible target for anti-inflammatory therapy...
  3. ncbi request reprint PF-04886847 (an inhibitor of plasma kallikrein) attenuates inflammatory mediators and activation of blood coagulation in rat model of lipopolysaccharide (LPS)-induced sepsis
    D Kolte
    School of Pharmacy, Department of Pharmacology, University of Mississippi, University, MS 38677 1848, USA
    Cardiovasc Hematol Agents Med Chem 10:154-66. 2012
    ..Although the findings of this study indicate that PF-04886847 possesses limited anti-thrombotic and anti-inflammatory effects, PF-04886847 may have therapeutic potential in other kallikrein-kinin mediated diseases...
  4. pmc Upregulation of prolylcarboxypeptidase (PRCP) in lipopolysaccharide (LPS) treated endothelium promotes inflammation
    My Linh Ngo
    School of Pharmacy, Department of Pharmacology, University of Mississippi, Oxford, MS, USA
    J Inflamm (Lond) 6:3. 2009
    ....